Response to neoadjuvant chemotherapy in patients with triple negative breast cancer

被引：0
|
作者：
Abe, E. [1 ]
Hayashi, N. [1 ]
Yoshida, A. [1 ]
Hamaoka, T. [1 ]
Yagata, H. [1 ]
Tsugawa, K. [1 ]
Tsunoda-Shimizu, H. [1 ]
Suzuki, K. [1 ]
Nakamura, S. [1 ]
机构：
[1] St Lukes Int Hosp, Tokyo, Japan
来源：
CANCER RESEARCH | 2009年 / 69卷 / 02期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：367S / 367S
页数：1
相关论文
共 50 条
  • [21] Monitoring of Triple Negative Breast Cancer After Neoadjuvant Chemotherapy
    Aldrich, Jeffrey
    Canning, Madison
    Bhave, Manali
    [J]. CLINICAL BREAST CANCER, 2023, 23 (08) : 832 - 834
  • [22] Neoadjuvant Versus Adjuvant Chemotherapy for Triple Negative Breast Cancer
    Kennedy, Carlie R.
    Gao, Feng
    Margenthaler, Julie A.
    [J]. JOURNAL OF SURGICAL RESEARCH, 2010, 163 (01) : 52 - 57
  • [23] Immunomodulation with dexamethasone in neoadjuvant chemotherapy for triple negative breast cancer
    Goldstein, Daniel
    Kassem, Mahmoud
    Quiroga, Dionisia
    Miah, Abdul
    Vargo, Craig
    Shinde, Namrata Vilas
    Berger, Michael
    Williams, Nicole
    Stover, Daniel
    Sardesai, Sagar
    Lustberg, Maryam
    Ramaswamy, Bhuvaneswari
    Tozbikian, Gary
    Schnell, Patrick
    Cherian, Mathew
    [J]. CANCER RESEARCH, 2021, 81 (04)
  • [24] Neoadjuvant Chemotherapy in Triple Negative Breast Cancer: An Observational Study
    Shao, Zhiying
    Chaudhri, Shalini
    Guo, Meng
    Zhang, Longzhen
    Rea, Daniel
    [J]. ONCOLOGY RESEARCH, 2016, 23 (06) : 291 - 302
  • [25] A predictor of pathological complete response to neoadjuvant chemotherapy in triple -negative breast cancer patients with the DNA repair genes
    Huang, Liang
    Lang, Guan-Tian
    Liu, Qi
    Shi, Jin-Xiu
    Shao, Zhi-Ming
    Cao, A-Yong
    [J]. ANNALS OF TRANSLATIONAL MEDICINE, 2021, 9 (04)
  • [26] Pathologic Response After Neoadjuvant Chemotherapy Predicts Locoregional Control in Patients With Triple-Negative Breast Cancer
    Gillespie, E.
    Chen, V. E.
    Murphy, J.
    Yashar, C. M.
    Lu, S. M.
    Einck, J. P.
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2014, 90 : S241 - S241
  • [27] Using machine learning approaches to predict response to neoadjuvant chemotherapy in patients with triple-negative breast cancer
    Fisher, Timothy Byron
    Li, Hongxiao
    Ts, Rekha
    Krishnamurthy, Jayashree
    Bhattarai, Shristi
    Janssen, Emiel A. M.
    Kong, Jun
    Aneja, Ritu
    [J]. CANCER RESEARCH, 2022, 82 (04)
  • [28] Bevacizumab in Neoadjuvant Chemotherapy Increases the Pathological Complete Response Rate in Patients With Triple-Negative Breast Cancer
    Barton, Mary Kay
    [J]. CA-A CANCER JOURNAL FOR CLINICIANS, 2014, 64 (03) : 155 - 156
  • [29] Pathological tumor response to neoadjuvant chemotherapy using anthracycline and taxanes in patients with triple-negative breast cancer
    Sakuma, Kaori
    Kurosumi, Masafumi
    Oba, Hanako
    Kobayashi, Yasuhito
    Takei, Hiroyuki
    Inoue, Kenichi
    Tabei, Toshio
    Oyama, Tetsunari
    [J]. EXPERIMENTAL AND THERAPEUTIC MEDICINE, 2011, 2 (02) : 257 - 264
  • [30] BRCAness and Prognosis in Triple-Negative Breast Cancer Patients Treated with Neoadjuvant Chemotherapy
    Tanino, Hirokazu
    Kosaka, Yoshimasa
    Nishimiya, Hiroshi
    Tanaka, Youko
    Minatani, Naoko
    Kikuchi, Mariko
    Shida, Akiko
    Waraya, Mina
    Katoh, Hiroshi
    Enomoto, Takumo
    Sengoku, Norihiko
    Kajita, Sabine
    Hoffman, Robert M.
    Watanabe, Masahiko
    [J]. PLOS ONE, 2016, 11 (12):
12345